हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Wang G
The field of transplantation medicine has witnessed remarkable advancements in recent years, driven by the emergence of cellular therapies. This abstract provides an overview of the transformative potential of cellular therapies in the context of transplantation. Cellular therapies represent a paradigm shift in the management of organ transplantation, offering a promising alternative to traditional transplantation methods. This abstract highlights key aspects of cellular therapies, including their mechanisms of action, applications, and potential benefits. First, the abstract discusses the fundamental principles underlying cellular therapies. These therapies involve the isolation, expansion, and manipulation of specific cell types, such as mesenchymal stem cells, regulatory T cells, and induced pluripotent stem cells. These cells can be utilized to modulate the immune system, repair damaged tissues, and induce transplant tolerance. Next, the abstract explores the diverse applications of cellular therapies in transplantation. From enhancing graft survival to reducing the reliance on immunosuppressive drugs, cellular therapies offer a versatile toolkit for transplant clinicians. Moreover, they hold promise for regenerative medicine approaches, allowing the repair and regeneration of injured or degenerated organs. Furthermore, this abstract delves into the potential benefits of cellular therapies. By reducing graft rejection rates, minimizing complications, and improving long-term outcomes, cellular therapies have the potential to revolutionize transplantation outcomes. Additionally, the mitigation of transplant-related morbidities and the prospect of personalized medicine approaches contribute to the allure of cellular therapies.